Follow-up surveillance strategies for genitourinary malignancies (Q34736606)

4 August 2017

Follow-up surveillance strategies for genitourinary malignancies (English)

1 reference

4 August 2017

Christopher P Evans

1

1 reference

PubMed ID

12115377

4 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

4 August 2017

14

1 reference

based on heuristic

inferred from page(s)

published in

Cancer

1 reference

4 August 2017

94

1 reference

4 August 2017

2892-2905

1 reference

4 August 2017

11

1 reference

Follow-up in prostate cancer patients: which parameters are necessary?

4 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Natural history of progression after PSA elevation following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Is there a role for digital rectal examination in the followup of patients after radical prostatectomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Efficacy of digital rectal examination after radiotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Radiation therapy (RT) after prostatectomy: The case for salvage therapy as opposed to adjuvant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

The treated natural history of high risk superficial bladder cancer: 15-year outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Urine based markers of urological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965-1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Heterogeneity of cancer surveillance practices among medical oncologists in Washington and Oregon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Clinical and molecular followup after radical retropubic prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Is Useless for the Detection of Local Recurrence after Radical Prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Radiotherapy for PSA recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Adjuvant radiotherapy following radical prostatectomy is more effective and less toxic than salvage radiotherapy for a rising prostate specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Late recurrence and progression after a long tumor-free period in primary Ta and T1 bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Urine cytology in the detection of bladder cancer: a critical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Identifying patients with low-risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Cost-effective strategies for the follow-up of patients with germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

PROGRESSION DETECTION OF STAGE I NONSEMINOMATOUS TESTIS CANCER ON SURVEILLANCE: IMPLICATIONS FOR THE FOLLOWUP PROTOCOL

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Late relapse of clinical stage I testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?--Results of a study in 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Clinical characteristics of metachronous bilateral testicular tumors in the chemotherapeutic era

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Second malignancies following pure seminoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Proposal for changes in cystoscopic follow-up of patients with low-grade pTa bladder tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

Changing trends in partial nephrectomy at Walter Reed Army Medical Center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

inferred from DOI database lookup

7 January 2021

based on heuristic

Evaluation of urinary level of NMP22 as a diagnostic marker for stage pTa-pT1 bladder cancer: comparison with urinary cytology and BTA test

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10525

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.10525

1 reference

4 August 2017

1 reference

PubMed ID

12115377